CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a novel drug delivery system using microvesicles to improve the targeting and efficacy of biological drugs, particularly nucleic acids. The goal is to address the challenges of current delivery systems and meet the medical needs for more effective therapies.
Biological drugs such as proteins and nucleic acids have poor bioavailability, are subject to degradation and denaturation and need to be delivered to a specific cell type and sometimes even a specific organelle to be active.
Therefore, they require a drug delivery system to bring them to the target site.
However, the current available drug delivery systems lack efficiency, resulting in poor efficacy of biological drugs particularly of nucleic acids.
Consequently, a large number of nucleic acids…
UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
